Delivery Order SPE2DB20D2104-SPE2DB24FR02G
- Not listed
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,781.44, is for the delivery of Doxepin HCL 3 mg tablets. This is a Firm Fixed Price Delivery Order that does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,826.21, is a firm fixed-price delivery order for 4,563,169,498 units of the pharmaceutical product Doxepin HCL 6 mg Tablet 30s. The contract has an ultimate completion date of December 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,767.93, is for the delivery of Doxepin HCL 3 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on January 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. It is a Delivery Order worth $7,346.29 under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract is for 4,565,504,752 Doxepin 75 mg capsules,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,496.81, is for the supply of 4567602341 - Doxepin HCL 3 mg Tablets, 30s. The award has a firm fixed price and an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
- This federal contract award, with ID SPE2DB22D3009|SPE2DB24FAH42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,461.97, is for the delivery of Doxepin HCL 3 mg tablets in quantities of 30s. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 1, 2023. This award is not designated as a Set-Aside contract....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $2,253.60, is for the supply of Doxepin Hydrochloride 3 mg tablets to support federal healthcare programs. The contract does not have a set-aside designation, indicating open competition. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award, valued at $3,592.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Doxepin HCL 3 mg tablets to support military and veteran healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract, valued at $7,621.20, is for the delivery of 6 mg doxepin hydrochloride tablets. The contract has a completion date of January 11, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov)....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568603966 - Doxepin HCL 3 MG Tablet 30S, with a ceiling value of $1,038.16. The contract is a firm fixed-price delivery order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR02GDelivery Order
This federal contract award, valued at $13,339.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of Doxepin HCL 6 mg tablets, a medication used to treat mental health conditions. This award is not designated under any set-aside program, indicating open competition. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen's extensive pharmaceutical and medical supply distribution capabilities support the procurement of essential medical commodities for the DLA and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 11/2/23 |